Loading...
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
<p>Abstract</p> <p>Background</p> <p>Lymphomas frequently retain wild-type (wt) p53 function but overexpress HDM2, thereby compromising p53 activity. Therefore, lymphoma is a suitable model for studying the therapeutic value of disrupting the HDM2-p53 interaction by sma...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BMC
2012-09-01
|
Serier: | Journal of Hematology & Oncology |
Fag: | |
Online adgang: | http://www.jhoonline.org/content/5/1/57 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|